237 related articles for article (PubMed ID: 32229678)
1. Pulsed low dose-rate irradiation response in isogenic HNSCC cell lines with different radiosensitivity.
Todorovic V; Prevc A; Zakelj MN; Savarin M; Bucek S; Groselj B; Strojan P; Cemazar M; Sersa G
Radiol Oncol; 2020 Mar; 54(2):168-179. PubMed ID: 32229678
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines.
Todorovic V; Prevc A; Zakelj MN; Savarin M; Brozic A; Groselj B; Strojan P; Cemazar M; Sersa G
Radiat Oncol; 2019 Nov; 14(1):214. PubMed ID: 31775835
[TBL] [Abstract][Full Text] [Related]
3. Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity.
Todorovic V; Groselj B; Cemazar M; Prevc A; Zakelj MN; Strojan P; Sersa G
Radiol Oncol; 2022 Apr; 56(2):173-184. PubMed ID: 35390246
[TBL] [Abstract][Full Text] [Related]
4. Different mechanisms of cell death in radiosensitive and radioresistant p53 mutated head and neck squamous cell carcinoma cell lines exposed to carbon ions and x-rays.
Maalouf M; Alphonse G; Colliaux A; Beuve M; Trajkovic-Bodennec S; Battiston-Montagne P; Testard I; Chapet O; Bajard M; Taucher-Scholz G; Fournier C; Rodriguez-Lafrasse C
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):200-9. PubMed ID: 19362238
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis.
Naz S; Leiker AJ; Choudhuri R; Preston O; Sowers AL; Gohain S; Gamson J; Mathias A; Van Waes C; Cook JA; Mitchell JB
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1295-1305. PubMed ID: 33838214
[TBL] [Abstract][Full Text] [Related]
6. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines.
Aldridge DR; Radford IR
Cancer Res; 1998 Jul; 58(13):2817-24. PubMed ID: 9661896
[TBL] [Abstract][Full Text] [Related]
7. Radioresistant head and neck squamous cell carcinoma cells: intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets.
Skvortsov S; Jimenez CR; Knol JC; Eichberger P; Schiestl B; Debbage P; Skvortsova I; Lukas P
Radiother Oncol; 2011 Oct; 101(1):177-82. PubMed ID: 21700351
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CDK4/CDK6 Enhances Radiosensitivity of HPV Negative Head and Neck Squamous Cell Carcinomas.
Göttgens EL; Bussink J; Leszczynska KB; Peters H; Span PN; Hammond EM
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):548-558. PubMed ID: 31271827
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity.
Kuo ML; Hwang HS; Sosnay PR; Kunugi KA; Kinsella TJ
Cancer J; 2003; 9(4):277-85. PubMed ID: 12967138
[TBL] [Abstract][Full Text] [Related]
10. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
[TBL] [Abstract][Full Text] [Related]
11. Proteomics of the radioresistant phenotype in head-and-neck cancer: Gp96 as a novel prediction marker and sensitizing target for radiotherapy.
Lin TY; Chang JT; Wang HM; Chan SH; Chiu CC; Lin CY; Fan KH; Liao CT; Chen IH; Liu TZ; Li HF; Cheng AJ
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):246-56. PubMed ID: 20615631
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma.
Odhiambo DA; Pittman AN; Rickard AG; Castillo RJ; Bassil AM; Chen J; Ravotti ML; Xu ES; Himes JE; Daniel AR; Watts TL; Williams NT; Luo L; Kirsch DG; Mowery YM
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1315-1327. PubMed ID: 38104870
[TBL] [Abstract][Full Text] [Related]
13. The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers.
Huang J; Meng Q; Liu R; Li H; Li Y; Yang Z; Wang Y; Wanyan C; Yang X; Wei J
Clin Transl Oncol; 2023 Oct; 25(10):3006-3020. PubMed ID: 37029240
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of radiosensitivity in head and neck squamous cell carcinoma.
Li G; Jiang Y; Li G; Qiao Q
Radiother Oncol; 2021 Jun; 159():126-135. PubMed ID: 33775714
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of lncRNA BLACAT1 enhances radiosensitivity of head and neck squamous cell carcinoma cells by regulating PSEN1.
Gou C; Han P; Li J; Gao L; Ji X; Dong F; Su Q; Zhang Y; Liu X
Br J Radiol; 2020 Apr; 93(1108):20190154. PubMed ID: 31944856
[TBL] [Abstract][Full Text] [Related]
16. Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens.
Meneceur S; Löck S; Gudziol V; Hering S; Bütof R; Rehm M; Baumann M; Krause M; von Neubeck C
Radiother Oncol; 2019 Aug; 137():24-31. PubMed ID: 31048234
[TBL] [Abstract][Full Text] [Related]
17. Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts.
Zakelj MN; Prevc A; Kranjc S; Cemazar M; Todorovic V; Savarin M; Scancar J; Kosjek T; Groselj B; Strojan P; Sersa G
Oncol Rep; 2019 Mar; 41(3):1658-1668. PubMed ID: 30628709
[TBL] [Abstract][Full Text] [Related]
18. Characterization of FaDu-R, a radioresistant head and neck cancer cell line, and cancer stem cells.
Cho KJ; Park EJ; Kim MS; Joo YH
Auris Nasus Larynx; 2018 Jun; 45(3):566-573. PubMed ID: 28844650
[TBL] [Abstract][Full Text] [Related]
19. The impact of CDK9 on radiosensitivity, DNA damage repair and cell cycling of HNSCC cancer cells.
Storch K; Cordes N
Int J Oncol; 2016 Jan; 48(1):191-8. PubMed ID: 26573875
[TBL] [Abstract][Full Text] [Related]
20. Role of cancer stem cell in radioresistant head and neck cancer.
Park YM; Lee SY; Park SW; Kim SH
Auris Nasus Larynx; 2016 Oct; 43(5):556-61. PubMed ID: 26860233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]